Vanderbilt researchers have made a significant breakthrough in the fight against Alzheimer's disease, creating two new compounds that could help reveal the underlying mechanisms of the disease.
Key Insights
The researchers created a selective compound to inhibit TAOK-1, a protein connected to Alzheimer's disease, and a second compound that activates the entire TAOK protein family. These compounds could reveal hidden disease mechanisms and point toward new treatment strategies, bringing hope for the development of novel therapies to combat Alzheimer's disease.









